Yes, quite right. That's the trouble with having too many tabs open at the same time and so many CHM trials on the go! Thanks, again, reon.
So, we have yet to receive any news regarding CORE-NK with Vactosertib for bowel cancer? But have the CR at 28-days in AML in combo with the other novel drugs.
MDA are being tight-lipped with the ADVENT-AML progress (other than its safe to progress to the next stage). I guess they have nothing to gain by unveiling efficacy signals (if any) beyond what is expected for the SOC therapies.
- Forums
- ASX - By Stock
- Ann: Dose finding complete in ADVENT-AML Phase 1b clinical trial
CHM
chimeric therapeutics limited
Add to My Watchlist
0.00%
!
0.4¢

Yes, quite right. That's the trouble with having too many tabs...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $100 | 25K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
28 | 21874000 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 19510638 | 27 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
28 | 21874000 | 0.004 |
37 | 23631939 | 0.003 |
15 | 13500507 | 0.002 |
9 | 49600000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 19510638 | 27 |
0.006 | 23500718 | 17 |
0.007 | 4700000 | 4 |
0.008 | 8542434 | 6 |
0.009 | 2767672 | 5 |
Last trade - 15.25pm 17/06/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ronald Miller, Non-Executive Director
Ronald Miller
Non-Executive Director
SPONSORED BY The Market Online